Posters

Outcomes of unilateral and bilateral congenital cataract surgery in Lithuania

Poster Details

First Author: G.Laurinavičiūtė LITHUANIA

Co Author(s):    L. Pozeraite   R. Zemaitiene   J. Zukauskas   A. Gelzinis   V. Jasinskas        

Abstract Details

Purpose:

To evaluate postoperative outcomes of unilateral and bilateral congenital cataract surgeries performed in Kaunas, Lithuania.

Setting:

Medical Academy, Department of Ophthalmology, Lithuanian University of Health Sciences, Kaunas, Lithuania

Methods:

Clinical records of 84 (121 eyes) children under 18 years who underwent cataract surgery between 2006 and 2015 were reviewed retrospectively. Patients with traumatic cataract, congenital glaucoma, prematurity were excluded. Minimum follow-up period was 1 month. We evaluated cataract laterality, surgical procedure (extracapsular cataract extraction (ECCE) with or without intraocular lens (IOL) implantation), best corrected visual acuity (BCVA), the presence of nystagmus, amblyopia at last follow-up and postoperative complications (posterior capsule opacification (PCO) and aphakic glaucoma) of unilateral (group 1) and bilateral (group 2) cataracts.

Results:

The mean age at surgery in group 1(37;37 eyes) was 50.1±57.2 months, in group 2(47;84 eyes) – 63.4±53.4 months. ECCE with IOL implantation was performed in 48.7% in group 1, 67.9% in group 2. Mean follow-up was 44.4±36.7 months in group 1 and 47.6±34.1 months in group 2. PCO was observed in 40.5%, aphakic glaucoma–21.6% cases within group 1, correspondingly 60.7% and 14.3% within group 2. BCVA was >=10/20 in 11.5% of cases, nystagmus – 5.4%, amblyopia – 81.0% in group 1 at last follow-up, respectively BCVA >= 10/20 – 61.2%, nystagmus – 19.0%, amblyopia – 61.9% in group 2.

Conclusions:

There were more IOLs implanted in patients with bilateral cataract (p<0.05). Rate of amblyopia at last follow-up in cases with unilateral cataract was higher than in bilateral, whereas PCO and BCVA more than 10/20 were more common in cases with bilateral cataract (p<0.05).

Financial Disclosure:

NONE